FH-Australasia and the AAS Familial Hypercholesterolaemia Sub-Committee is a dedicated team of clinicians and scientists from around Australia and New Zealand. Activities currently underway include the development of management guidelines, information sessions for clinicians, and the establishment of various services around the country.

The AAS is also delighted to be the coordinating organisation for MEDPED Australia and Asia-Pacific. MEDPED stands for Make Early Diagnosis to Prevent Early Deaths. It is an international research project and a nonprofit organization funded to register and help treat people with inherited cholesterol disorders, such as Familial Hypercholesterolemia (FH). The goal is to find persons with FH that are either undiagnosed or inadequately treated and help them with finding a diagnosis and the right treatment.